Functional Characterization Experiment summary for ENCSR397CXJ

doi:10.17989/ENCSR397CXJ

Supersedes ENCSR833EYM

Summary

Status
released
Assay
proliferation CRISPR screen
Biosample summary
Homo sapiens K562, 21 days post-nucleic acid delivery time genetically modified (insertion) using transduction, using CRISPRa (sgRNA) for multiple loci
Biosample Type
cell line
Perturbation type
CRISPRa
Tiling modality
full tiling
Replication type
isogenic
Description
Tiling, dCas9-VPR/CRISPRa proliferation screen at the GATA1, MYB, and ZMYND8 loci
Treatments
1 μg/mL Puromycin (CHEBI:17939) for 96 hours
Nucleic acid type
DNA
Extraction method
QIAGEN DNeasy Blood & Tissue Kit
Elements references
Elements cloning
ENCSR479VDK

Attribution

ENCODE4 project
Lab
Will Greenleaf, Stanford
Award
UM1HG009436 (Will Greenleaf, Stanford)
Project
ENCODE
References
Aliases
will-greenleaf:CRISPR_GATA1_tiling.CRISPRa_T21
Date released
December 14, 2021
Functional Characterization Series
ENCSR882EWB 

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Modifications
Library
11Homo sapiens K562 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRa (sgRNA) treated with 1 μg/mL Puromycin for 96 hours, 21 days post-nucleic acid delivery timeENCBS074QCTENCGM440XJM, ENCGM484HMCENCLB025SBM
21Homo sapiens K562 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRa (sgRNA) treated with 1 μg/mL Puromycin for 96 hours, 21 days post-nucleic acid delivery timeENCBS409YJFENCGM440XJM, ENCGM484HMCENCLB543BBG